Carregant...
P06.04 By reversing tumor hypoxia, omx, an ind-stage drug candidate, promotes anti-tumor response and increases survival in the gl261 intracranial glioblastoma model
Intratumoral hypoxia is a common feature in solid tumors such as glioblastoma (GB). Hypoxic tumor cells develop aggressive phenotypes and resistance to chemo- and radio-therapies leading to poor patient outcomes. In addition, hypoxia promotes the immune escape of tumors via Treg recruitment and acti...
Guardat en:
| Publicat a: | Neuro Oncol |
|---|---|
| Autors principals: | , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
Oxford University Press
2017
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5463933/ https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/neuonc/nox036.178 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|